Posted inTechnology News FDA regulator gives cool reception to drug Lilly licensed from Chinese firm – Stat News Posted by 5 February 2022 Illumina’s embrace of long-read technology signals a shift in the DNA-sequencing market … Reporting from the frontiers of health and medicine. View All Posts Post navigation Previous Post Cancer moonshot 2.0: A missed opportunity for prevention – Stat NewsNext PostThe Metaverse calls: NFTs construct virtual economies to stay relevant in 2022